Glaxosmithkline Pharmaceuticals Ltd.

₹3167.6

Glaxosmithkline Pharmaceuticals Ltd.

₹3167.6

₹3167.6

-31.7 (-0.99%) - 16 Jul 2025 04:27 PM

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹ 54,198 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 58.97
P/B Ratio 27.81
Enterprise Value ₹ 52,907 Cr.
ROE % 48.92
RSI Value 41.12
EMA 50 3165.72
EMA 200 2766.17
Market Cap. ₹ 54,198 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 58.43
P/B Ratio 27.77
Enterprise Value ₹ 52,905 Cr.
ROE % 49.43
RSI Value 41.12
EMA 50 3165.72
EMA 200 2766.17

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.